NCT04115800View on ClinicalTrials.gov

Liposomal Sirolimus in Dry Eye Disease

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 2, 2019

Primary Completion Date

May 1, 2020

Study Completion Date

August 1, 2020

Conditions
Dry Eye
Interventions
DRUG

Liposomal Sirolimus

Subconjunctival injections of liposomal sirolimus in patients with conventional treatment with moderate and severe dry deye disease

Trial Locations (1)

06800

Instituto de Oftalmología, Mexico City

All Listed Sponsors
lead

Instituto de Oftalmología Fundación Conde de Valenciana

OTHER

NCT04115800 - Liposomal Sirolimus in Dry Eye Disease | Biotech Hunter | Biotech Hunter